Speciality chemicals manufacturer, Rossari Biotech Ltd on Friday said that it has raised Rs148.87 crore from anchor investors, ahead of its IPO that opens on 13 July. Institutional investors that participated in the...
Japan’s AGC weighs options after Italy puts conditions on Molmed deal
Italy said it would use its right to intervene to protect strategic assets on the planned acquisition of biotechnology group Molmed by AGC, leaving the Japanese buyer to review whether to go ahead with its offer. After...
Novozymes buys Irish probiotic maker PrecisionBiotics
Danish enzyme maker Novozymes NZYMB.CO will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics company in recent years as it seeks to grow its human...
Japan’s AGC launches bid for Italian biotech firm Molmed
Japan’s AGC has launched a takeover bid on the whole of Italian biotech company Molmed in a deal worth up to 240 million euros ($267 million), AGC said on Tuesday. In its bid document, the Japanese conglomerate said it...
Asia Healthcare in talks to buy Cloudnine stake
TPG Growth-backed Asia Healthcare Holdings (AHH) has held early discussions to acquire a significant stake in maternity and childcare hospital chain Cloudnine, multiple people in the know of the development told ET. A...
Nestle invests $200 million more in Aimmune after peanut allergy drug approval
Aimmune Therapeutics Inc said on Wednesday the health science arm of Nestle SA will invest an additional $200 million, days after the drugmaker won U.S. approval for its peanut allergy therapy, touted as a potential...
Danaher gets conditional South Korean regulatory nod for $21 billion GE biopharma unit deal
South Korea’s antitrust watchdog has approved Danaher Corp’s proposed $21.4 billion acquisition of General Electric’s biopharma division on condition that they sell certain assets to address monopoly concerns. The U.S...
Illumina abandons $1.2 billion deal to buy rival Pacific Biosciences
Illumina Inc (ILMN.O) on Thursday agreed to terminate the $1.2 billion deal to buy smaller rival Pacific Biosciences of California Inc (PACB.O), weeks after the U.S. competition watchdog filed a complaint to block the...
FTC files complaint to block Illumina from buying PacBio
The Federal Trade Commission has filed a complaint aimed at stopping Illumina Inc from purchasing Pacific Biosciences of California, the agency said on Tuesday. Shares of PacBio fell about 7.5 percent in after-hours...
Reliance’s biotech arm eyes tie-ups to enter diagnostics business
Mukesh Ambani, India’s richest man, now wants a share of your diagnostics budget, in a move that can potentially shake up the sector similar to the disruption in the telecom market after the entry of Reliance Jio...
NCLAT gives 30 days more to Sterling Biotech promoters to settle dues
The National Company Law Appellate Tribunal has granted 30 days more to the promoters of Sterling Biotech to settle dues of creditors, failing which liquidation process of the company will start. A three-member bench...
Advent set to buy controlling stake in Bharat Serum
Private equity group Advent International is buying a controlling stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV), valuing the company for $500 million (Rs 3500 cr). A formal announcement is...
